Eli Lilly & Co.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $7.97B | $14.57B | $3.67B |
| FY2016 | $8.37B | $14.01B | $4.58B |
| FY2017 | $9.94B | $11.59B | $6.54B |
| FY2018 | $9.20B | $9.83B | $7.32B |
| FY2019 | $13.82B | $2.61B | $2.34B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $7.97B | $14.57B | $3.67B |
| FY2016 | $8.37B | $14.01B | $4.58B |
| FY2017 | $9.94B | $11.59B | $6.54B |
| FY2018 | $9.20B | $9.83B | $7.32B |
| FY2019 | $13.82B | $2.61B | $2.34B |